Magenta Therapeutics, Inc. Intellectual Property Contracts & Agreements

6 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. 3, effective as of August 1, 2022, to the Exclusive Research, Development Option and License Agreement by and between the Registrant and Heidelberg Pharma Research...
License Agreements
Magenta Therapeutics, Inc.
Biotechnology
NY
2022
Amendment, effective as of July 4, 2019, pursuant to the Exclusive Research, Development Option and License Agreement by and between the Registrant and Heidelberg Pharma Research...
License Agreements
Magenta Therapeutics, Inc.
Biotechnology
2019
Letter Agreement, effective as of February 28, 2019, by and between the Registrant and Heidelberg Pharma Research GmbH relating to the Exclusive Research, Development Option and...
License Agreements
Magenta Therapeutics, Inc.
Biotechnology
2019
Exclusive Research, Development Option and License Agreement by and between Heidelberg Pharma Research GmbH and the Registrant, dated as of March 1, 2018
License Agreements
Magenta Therapeutics, Inc.
Biotechnology
NY
2018
License Agreement by and between Novartis International Pharmaceutical Ltd. and the Registrant, dated as of April 3, 2017
License Agreements
Magenta Therapeutics, Inc.
Biotechnology
NY
2018
License Agreement by and between President and Fellows of Harvard College and the Registrant, dated as of November 2, 2016
License Agreements
Magenta Therapeutics, Inc.
Biotechnology
MA
2018